scispace - formally typeset
I

Ian O. Ellis

Researcher at University of Nottingham

Publications -  1071
Citations -  84964

Ian O. Ellis is an academic researcher from University of Nottingham. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 126, co-authored 1051 publications receiving 75435 citations. Previous affiliations of Ian O. Ellis include Mansoura University & Curie Institute.

Papers
More filters
Journal ArticleDOI

Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens.

Anne‐Marie O’Shea, +4 more
- 01 Sep 2011 - 
TL;DR: O’Shea A‐M, Rakha E A, Hodi Z, Ellis I O & Lee A H S’(2011) Histopathology59, 543–548.
Journal ArticleDOI

Redox protein expression predicts radiotherapeutic response in early-stage invasive breast cancer patients.

Caroline M. Woolston, +5 more
- 01 Apr 2011 - 
TL;DR: The results support the use of redox protein expression, namely glutathione S-transferase-θ and glutathion peroxidase 3, to predict the response to radiotherapy in early-stage breast cancer patients.
Journal ArticleDOI

Papillary carcinoma of the breast: diagnostic agreement and management implications

Emad A. Rakha, +2 more
- 01 Nov 2016 - 
TL;DR: Assessment of the diagnostic agreement regarding PC among reporting breast pathologists found that there is little agreement on the diagnostic categorization of PC as in‐situ and invasive disease.
Journal ArticleDOI

Primary malignant mesenchymal tumour of the liver in an elderly female.

Ian O. Ellis, +1 more
- 01 Jan 1983 - 
TL;DR: A case of primary malignant mesenchymal tumour of the liver occurring in an 86‐year‐old woman described, which was large, rapidly growing though well circumscribed and extensively necrotic.
Journal ArticleDOI

Biological and clinical implications of nicastrin expression in invasive breast cancer

Aleksandra Filipovic, +10 more
- 01 Jan 2011 - 
TL;DR: Data indicate that nicastrin can function to maintain epithelial to mesenchymal transition during BC progression, and supports the hypothesis that a Nicastrin blocking antibody could be used to limit metastatic dissemination in invasive BC.